These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15517893)

  • 21. The small-molecule tyrosine kinase inhibitor nilotinib is a potent noncompetitive inhibitor of the SN-38 glucuronidation by human UGT1A1.
    Fujita K; Sugiyama M; Akiyama Y; Ando Y; Sasaki Y
    Cancer Chemother Pharmacol; 2011 Jan; 67(1):237-41. PubMed ID: 20814789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38) by the human UDP-glucuronosyltransferases encoded at the UGT1 locus.
    Ciotti M; Basu N; Brangi M; Owens IS
    Biochem Biophys Res Commun; 1999 Jun; 260(1):199-202. PubMed ID: 10381366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucuronidation of SN-38 and NU/ICRF 505 in human colon cancer and adjacent normal colon.
    Cummings J; Ethell BT; Jardine L; Burchell B
    Anticancer Res; 2006; 26(3B):2189-96. PubMed ID: 16821585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucuronidation of OTS167 in Humans Is Catalyzed by UDP-Glucuronosyltransferases UGT1A1, UGT1A3, UGT1A8, and UGT1A10.
    Ramírez J; Mirkov S; House LK; Ratain MJ
    Drug Metab Dispos; 2015 Jul; 43(7):928-35. PubMed ID: 25870101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemosensitivity determinants of irinotecan hydrochloride in hepatocellular carcinoma cell lines.
    Takahata T; Ookawa K; Suto K; Tanaka M; Yano H; Nakashima O; Kojiro M; Tamura Y; Tateishi T; Sakata Y; Fukuda S
    Basic Clin Pharmacol Toxicol; 2008 Apr; 102(4):399-407. PubMed ID: 18248513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucuronidation of PhIP and N-OH-PhIP by UDP-glucuronosyltransferase 1A10.
    Dellinger RW; Chen G; Blevins-Primeau AS; Krzeminski J; Amin S; Lazarus P
    Carcinogenesis; 2007 Nov; 28(11):2412-8. PubMed ID: 17638922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A humanized UGT1 mouse model expressing the UGT1A1*28 allele for assessing drug clearance by UGT1A1-dependent glucuronidation.
    Cai H; Nguyen N; Peterkin V; Yang YS; Hotz K; La Placa DB; Chen S; Tukey RH; Stevens JC
    Drug Metab Dispos; 2010 May; 38(5):879-86. PubMed ID: 20124398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucuronidation as a mechanism of intrinsic drug resistance in human colon cancer: reversal of resistance by food additives.
    Cummings J; Ethell BT; Jardine L; Boyd G; Macpherson JS; Burchell B; Smyth JF; Jodrell DI
    Cancer Res; 2003 Dec; 63(23):8443-50. PubMed ID: 14679008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pregnane X Receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation.
    Raynal C; Pascussi JM; Leguelinel G; Breuker C; Kantar J; Lallemant B; Poujol S; Bonnans C; Joubert D; Hollande F; Lumbroso S; Brouillet JP; Evrard A
    Mol Cancer; 2010 Mar; 9():46. PubMed ID: 20196838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for etoposide glucuronidation in human liver and intestinal microsomes: structural characterization of phenolic and alcoholic glucuronides of etoposide and estimation of enzyme kinetics.
    Wen Z; Tallman MN; Ali SY; Smith PC
    Drug Metab Dispos; 2007 Mar; 35(3):371-80. PubMed ID: 17151191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. UGT1A1*28 genotype affects the in-vitro glucuronidation of thyroxine in human livers.
    Yoder Graber AL; Ramírez J; Innocenti F; Ratain MJ
    Pharmacogenet Genomics; 2007 Aug; 17(8):619-27. PubMed ID: 17622938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.
    Udomuksorn W; Elliot DJ; Lewis BC; Mackenzie PI; Yoovathaworn K; Miners JO
    Pharmacogenet Genomics; 2007 Dec; 17(12):1017-29. PubMed ID: 18004206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-performance liquid chromatographic assay for glucuronidation activity of 7-ethyl-10-hydroxycamptothecin (SN-38), the active metabolite of irinotecan (CPT-11), in human liver microsomes.
    Hanioka N; Jinno H; Nishimura T; Ando M; Ozawa S; Sawada J
    Biomed Chromatogr; 2001 Aug; 15(5):328-33. PubMed ID: 11507714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Irinotecan treatment in cancer patients with UGT1A1 polymorphisms.
    Innocenti F; Ratain MJ
    Oncology (Williston Park); 2003 May; 17(5 Suppl 5):52-5. PubMed ID: 12800608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance of UDP-glucuronosyltransferase 1A10 (UGT1A10) in the detoxification of polycyclic aromatic hydrocarbons: decreased glucuronidative activity of the UGT1A10139Lys isoform.
    Dellinger RW; Fang JL; Chen G; Weinberg R; Lazarus P
    Drug Metab Dispos; 2006 Jun; 34(6):943-9. PubMed ID: 16510539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of ketoconazole on glucuronidation by UDP-glucuronosyltransferase enzymes.
    Yong WP; Ramirez J; Innocenti F; Ratain MJ
    Clin Cancer Res; 2005 Sep; 11(18):6699-704. PubMed ID: 16166450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7.
    Innocenti F; Iyer L; Ramírez J; Green MD; Ratain MJ
    Drug Metab Dispos; 2001 May; 29(5):686-92. PubMed ID: 11302935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacology of irinotecan.
    Kuhn JG
    Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):39-42. PubMed ID: 9726089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional characterization of wild-type and variant (T202I and M59I) human UDP-glucuronosyltransferase 1A10.
    Jinno H; Saeki M; Tanaka-Kagawa T; Hanioka N; Saito Y; Ozawa S; Ando M; Shirao K; Minami H; Ohtsu A; Yoshida T; Saijo N; Sawada J
    Drug Metab Dispos; 2003 May; 31(5):528-32. PubMed ID: 12695339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human UDP-glucuronosyltransferase 1A1 is the primary enzyme responsible for the N-glucuronidation of N-hydroxy-PhIP in vitro.
    Malfatti MA; Felton JS
    Chem Res Toxicol; 2004 Aug; 17(8):1137-44. PubMed ID: 15310245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.